Table 2.

Genomic alterations associated with clinical and pathologic features in penile carcinomas

Genomic regionEventPa
Clinical stage III–IVRecurrenceT stage T3-T4Lymph node metastasisDeath
aCGH
 3p26.3–p25.1Loss0.0130.033nsnsns
 3p24.3–p22.2Loss0.0130.0100.001ns0.021
 3p22.2Loss0.0130.0330.032nsns
 3p22.2–p21.32Loss0.030nsnsnsns
 3p21.1–p14.3Loss0.0010.0330.032ns0.018
 3p14.1Loss0.022ns0.020ns0.048
 3p13–p11.1Loss0.004ns0.007nsns
 8p23.3–p11.21Lossns0.0410.010nsns
qPCR
DLC1-3Lossnsns0.0470.046ns
DLC1-7Lossnsnsns0.011ns
PPARG-1Loss0.005ns0.0190.003ns

Abbreviation: ns, not significant.

  • aCalculated using Fisher exact with P ≤ 0.05 for significance.